Hillstream BioPharma Presentations at 2020 AACR Virtual Annual Meeting II
19. Mai 2020 08:00 ET
|
Hillstream BioPharma, Inc.
CHESTER, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (“Hillstream”) today announced that two abstracts highlighting the progress of HSB-1216 (salinomycin QUATRAMER™)...
Hillstream BioPharma Granted Orphan Drug Designation for HSB-1216 (QUATRAMER Salinomycin) for Treatment of Small Cell Lung Cancer (SCLC)
06. Januar 2020 08:00 ET
|
Hillstream BioPharma, Inc.
Positive pre-clinical data with an emerging validated mechanism of action, Ferroptosis HSB-1216 is a novel therapeutic using the QUATRAMER formulation of a potent anti-Ferroptotic compounds,...